719 related articles for article (PubMed ID: 10984573)
1. Protecting research subjects--what must be done.
Shalala D
N Engl J Med; 2000 Sep; 343(11):808-10. PubMed ID: 10984573
[No Abstract] [Full Text] [Related]
2. The impact of escalating regulatory requirements on the conduct of clinical research.
Gordon BG; Kessinger A; Mann SL; Prentice ED
Cytotherapy; 2003; 5(4):309-13. PubMed ID: 12944237
[TBL] [Abstract][Full Text] [Related]
3. Improving protection for research subjects.
Steinbrook R
N Engl J Med; 2002 May; 346(18):1425-30. PubMed ID: 11986426
[No Abstract] [Full Text] [Related]
4. Protecting research subjects--the crisis at Johns Hopkins.
Steinbrook R
N Engl J Med; 2002 Feb; 346(9):716-20. PubMed ID: 11870258
[No Abstract] [Full Text] [Related]
5. Protecting human research subjects: ten common problems.
Puglisi T
Health Law News; 2000 Jun; 13(3):8, 15. PubMed ID: 12542046
[No Abstract] [Full Text] [Related]
6. Bioethical malpractice: risk and responsibilities in human research.
Noah BA
J Health Care Law Policy; 2004; 7(2):175-241. PubMed ID: 15573441
[No Abstract] [Full Text] [Related]
7. Federal report says protection of human subjects is threatened by numerous factors.
Maloney DM
Hum Res Rep; 1996 May; 11(5):1-3. PubMed ID: 11654438
[No Abstract] [Full Text] [Related]
8. Duke's hazards. Did medical experiments put patients needlessly at risk?
Kaplan S; Brownlee S
US News World Rep; 1999 May; 126(20):66-8, 70. PubMed ID: 10387890
[No Abstract] [Full Text] [Related]
9. Clinical trials face heightened scrutiny as science and commerce appear to merge.
Lorman AJ
J Biolaw Bus; 2001; 4(4):23-32. PubMed ID: 12751494
[TBL] [Abstract][Full Text] [Related]
10. Light, fast, and flexible: a new approach to regulation of human gene therapy.
Cregan JA
McGeorge Law Rev; 2000; 32(1):261-87. PubMed ID: 15709266
[No Abstract] [Full Text] [Related]
11. Regulating human gene therapy: legislative overreaction to human subject protection failures.
Leavitt WJ
Adm Law Rev; 2001; 53(1):315-41. PubMed ID: 16189905
[No Abstract] [Full Text] [Related]
12. Time for new rules on human subjects research?
Dresser R
Hastings Cent Rep; 1998; 28(6):23-4. PubMed ID: 9868606
[No Abstract] [Full Text] [Related]
13. United States regulatory requirements for research involving human subjects.
J Biolaw Bus; 1998; 1(2):39-53. PubMed ID: 12739542
[No Abstract] [Full Text] [Related]
14. When informed consent is not required in studies.
Maloney DM
Hum Res Rep; 2006 Jun; 21(6):3. PubMed ID: 17111532
[No Abstract] [Full Text] [Related]
15. Making clinical trials safer for human subjects.
Baram M
Am J Law Med; 2001; 27(2-3):253-82. PubMed ID: 11467112
[No Abstract] [Full Text] [Related]
16. The concept of the IRB and bureaucratic reality: an exchange of letters.
van Eys J; Levine RJ
IRB; 1984; 6(4):8-10. PubMed ID: 11649563
[No Abstract] [Full Text] [Related]
17. Federal investigation concludes that institutional review boards are in trouble.
Maloney DM
Hum Res Rep; 1998 Aug; 13(8):1-2. PubMed ID: 11657190
[No Abstract] [Full Text] [Related]
18. Institutional review boards, research on children, and informed consent of parents: walking the tightrope between encouraging vital experimentation and protecting subjects' rights.
Katerberg RJ
J Coll Univ Law; 1998; 24(3):545-79. PubMed ID: 16331880
[No Abstract] [Full Text] [Related]
19. Financial conflicts of interest in human subjects research: proposals for a more effective regulatory scheme.
Jordan KA
Wash Lee Law Rev; 2003; 60(1):15-109. PubMed ID: 16273696
[No Abstract] [Full Text] [Related]
20. Conflicts of interest in medical research: how much conflict should exceed legal boundaries?
Klanica K
J Biolaw Bus; 2005; 8(3):37-45. PubMed ID: 16459426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
